OurCrowd, the leading global investment platform and the most active venture capital investor in Israel, Perrigo, the world’s largest non-prescription drug company, and BOL Pharma, the leading medical cannabis company in Israel and an OurCrowd portfolio company, today announced that the consortium they established won the tender issued by the Israel Innovation Authority to operate CanNegev, a medical cannabis incubator which will be located in Yeruham in the south of Israel.

Read more here.